Home

Activity Overview

Source: na.eventscloud.com

Categories: Oncologists1, General Medicine News

Tags: ASH24

Tweets with this article

Medscape Oncology

🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf

NRG1 Fusions Emerge as New Target of Interest in Lung, Pancreatic Cancers

NRG1 fusion positivity has gained interest as a treatment target in lung and pancreatic cancer, leading to the FDA approval of zenocutuzumab in December 2024.

OncLive.com January 4, 2025

Novel CAR T-Cell Therapy Trial Advances to Third Cohort in Ovarian Cancer

A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its third cohort.

Targeted Oncology January 4, 2025

Fertility Counseling and Preservation in Patients With NHL | Blood Cancers Today

Researchers say barriers such as time constraints and financial limitations complicate fertility counseling and preservation for patients with lymphoma.

Blood Cancers Today January 4, 2025

Active Monitoring Is Noninferior to Guideline Concordant Care in Low-Risk DCIS

Rates of invasive cancer were noninferior when patients with low-risk ductal carcinoma in situ received active monitoring vs guideline concordant care.

OncLive.com January 4, 2025